Back to Journals » Patient Preference and Adherence » Volume 16

Acceptance of COVID-19 Vaccine and Its Associated Factors Among Ethiopian Population: A Systematic Review

Authors Bayou FD , Amare SN 

Received 4 February 2022

Accepted for publication 14 April 2022

Published 24 April 2022 Volume 2022:16 Pages 1093—1103

DOI https://doi.org/10.2147/PPA.S360174

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Johnny Chen



Fekade Demeke Bayou,1 Shambel Nigussie Amare2

1Department of Epidemiology, College of Medicine and Health Sciences, Jigjiga University, Jigjiga, Ethiopia; 2Department of Clinical Pharmacy, School of Pharmacy, College of Health and Medical Science, Haramaya University, Harar, Ethiopia

Correspondence: Fekade Demeke Bayou, Email [email protected]

Introduction: Coronavirus disease 2019 (COVID-19) is a global health threat. Millions of lives were lost to COVID-19 and it has caused a substantial economic crisis throughout the world. The development of coronavirus vaccines has pinned a new hope in combating the pandemic. The success of vaccination and development of herd immunity highly depend on the willingness to be vaccinated, not merely on the availability of a vaccine. This review aims to provide comprehensive evidence on acceptance of COVID-19 vaccine and its associated factors in Ethiopia.
Methods: Literature searching was done using PubMed, Google scholar and Science direct databases. Studies conducted in Ethiopia, published in English language from inception until January 9, 2022 were included. Retrieved articles were screened based on titles, abstracts and full text reading to identify studies that met the inclusion criteria. About 21 eligible studies were included in this systematic review. The data were extracted using a data extraction checklist.
Results: A total of 2058 records were retrieved, of which 21 were eligible for this systematic review. All of the articles were cross-sectional studies published in 2021. In Ethiopia, the level of COVID-19 vaccine acceptance ranged from 31.4% to 92.33%. The vaccine acceptance level was significantly associated with age groups, sex, educational status, perceived susceptibility, perceived benefit, knowledge about COVID-19 vaccine, and other socio-demographic factors.
Conclusion: A significant portion of the studies revealed vaccine acceptance level was low. Variation of vaccine acceptance was associated with socio-demographic factors (age, sex, educational status, etc.), information-related factors, and other health-related behaviors. Dissemination of clear and adequate information concerning the vaccine might be the required prior activity to increase acceptance of the vaccine. Hence, there should be a coordinated effort to halt the pandemic through increasing the acceptance of COVID− 19 vaccine.

Keywords: acceptance, COVID-19 vaccine, Ethiopia, systematic review

Introduction

Coronavirus disease (COVID-19) is a global health threat caused by a newly discovered coronavirus.1 It was first detected in the city of Wuhan, in the province of Hubei, in China at the end of December 2019.2 The principal mode of transmission is through exposure to respiratory droplets (close contact) carrying infectious virus. However, airborne transmission may be possible under circumstances.3 People with COVID-19 have had a wide range of manifestations ranging from mild symptoms to severe illness and death.4 Most people infected with the COVID-19 virus may experience mild to moderate respiratory illness and recover without requiring special treatment.1 Older adults and people who have severe underlying medical conditions such as cardiovascular disease, diabetes, chronic respiratory disease, and cancer are at higher risk of developing more serious complications.1,4 The World Health Organization (WHO) recommends to keep simple precautions such as physical distancing, wearing a face mask, keeping rooms well ventilated, avoiding crowds, and frequent hand washing.5 In spite of such preventive measures, the pandemic is still increasing. At the beginning of January 2022, there were over 304 million confirmed cases of COVID-19, and 5.4 million deaths have been reported.6 As the COVID-19 pandemic continues, governments worldwide have pinned their hopes on the development of the vaccine.7,8

The WHO recommends that everyone should have access to the vaccine as quickly as possible, starting with those at highest risk of serious disease or death.6,9 However, the newly established COVID-19 vaccines have faced much hesitancy from the start, with the lowest vaccine acceptance rates found in Kuwait (23.6%), Jordan (28.4%), Italy (53.7), Russia (54.9%), Poland (56.3%), USA (56.9%), and France (58.9%).10 Moreover, rate of willingness to receive the vaccine ranged from 27.7% (in Congo) to 91.3% (in China).11

The COVID-19 pandemic has led to a dramatic loss of human life worldwide and presents an unprecedented challenge to public health, food systems, and the world of work.12 COVID-19 has had a strong impact on both developed and developing countries with fragile economies. It leaves the biggest negative effects on production networks, with a significant reduction in agricultural activities, tourism, trade, and industry.13 The economic and social disruption caused by the pandemic is devastating.12,14 In Ethiopia, the first COVID-19 case was reported in March 2020.15 Immediately after the first confirmed case, the Government of Ethiopia took several public health measures to prevent widespread infection.16 However the current status indicates the pandemic is still escalating in the country. Until April 4, 2021, there were 213,311 confirmed cases of COVID-19 and 2936 deaths.9 Moreover the pandemic exacerbated the prevailing health and socioeconomic threats as it has coexisted with the upsurge of desert locusts, social unrest and flooding in the country.17 As a result an estimated 6.7 million people were projected to be highly food insecure between October and December 2020.18 Study findings also indicated that there was a high prevalence of COVID-19 related depression, anxiety, and stress in Ethiopia.19,20

Ethiopia received supplies of the vaccination against COVID-19 in the first week of March 2021 to vaccinate 20% of the target population by the end of 2021.15,21 The success of effective vaccination and development of herd immunity in the population is highly dependent on the willingness to be vaccinated by the community, not merely on the availability of the vaccine.22 Individual studies conducted in different regions of Ethiopia revealed fragmented information about acceptance of the vaccine.23 A comprehensive systematic review of domestic studies is an important input for decision making, public health interventions, and controlling the pandemic in the country. This review is aimed at providing comprehensive evidence on acceptance of the COVID-19 vaccine and its associated factors in Ethiopia.

Methods

Search Strategy

This systematic review included relevant cross-sectional studies conducted in Ethiopia and published until January 2022. Search of literatures was done using three databases, namely PubMed, Google scholar and Science direct, using a combination of search terms that consists of “acceptance”, “COVID-19”, “vaccine”, “willingness”, “hesitancy”, and “Ethiopia”. Manual search of articles was performed to look for grey literatures. The two authors (FDB and SNA) independently identified articles from the databases, screened for eligibility and extracted relevant information. A total of 2058 papers were identified from the selected databases and Google, of which 21 were eligible for systematic review (Figure 1). We have also adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline on conducting and reporting this systematic review.

Figure 1 PRISMA flow diagram of the literature screening process.

Notes: PRISMA figure adapted from Moher D, Liberati A, Altman D, Tetzlaff J,et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Journal of clinical epidemiology. 2009;62(10).50

Eligibility Criteria

We included all cross-sectional studies that addressed the topic among the Ethiopian population, published in English language, and articles published until January 9, 2022. We excluded preprints, commentaries, poor quality studies which did not clearly report the acceptance of the vaccine and factor(s) related with vaccine acceptance and studies with inaccessible full texts (Figure 1).

Data Extraction

The collected records from searched databases were exported to Endnote version 7 software, and the duplicates were removed. Studies retrieved using the search engines were screened based on titles, abstracts and full text reading to identify studies that fulfill the inclusion criteria. The authors, independently, assessed the eligibility of each study and disagreements regarding inclusion of the studies were settled through discussion until concordance was reached. All studies screened by their title and abstract were read and re-read repeatedly to ease data extraction and further summarization of the results. Authors’ first names, year of publication, sample size, level of vaccine acceptance, and factors associated with vaccine acceptance were included into the data extraction format.

Outcome of Interest

In this systematic review, level of COVID-19 vaccine acceptance (%), level of willingness to receive COVID-19 vaccine (%), and level of COVID-19 vaccine hesitancy (%) were the primary outcomes of interest. Socio-demographic, cultural, and health behavior related determinant factors were the secondary outcomes of interest.

Quality Assessment of Individual Studies

The two authors independently appraised the quality of individual studies. The Joanna Briggs Institute (JBI) quality appraisal checklist was used to evaluate the quality of the studies.24 Studies that scored below 50% of the JBI evaluation checklist were referred as poor quality. Any disagreement between the authors during the appraisal process was discussed and resolved.

Ethical Consideration

This is the first systematic review conducted to summarize acceptance of COVID-19 vaccine in Ethiopia. Since this was a systematic review, which employed data extraction from already published research articles, it did not need a formal ethical approval and consent from participants.

Result

Characteristics of Included Studies

In this systematic review a total of 21 published articles were included. All of the articles were cross-sectional studies conducted in different areas and among different population groups of Ethiopia. All of the articles were published in the year 2021. The majority of the studies (17) were institution-based cross-sectional studies and the remaining four studies were community-based studies. The studies recruited various numbers of participants and sample sizes ranging from 232 to 2178 individuals. The study participants include health-care workers, patients, general population, school teachers and students (Table 1).

Table 1 Characteristics of the Included Studies on the Acceptance of COVID-19 Vaccine in Ethiopia

Acceptance of COVID-19 Vaccine

The acceptance level of COVID-19 vaccine has a potential variation among the reviewed studies. The smallest level was 31.4%25 whereas the largest was 92.33%.26 Nearly half (10) of the studies reported vaccine acceptance of less than 50%.25,27–35

Factors Associated with Acceptance of COVID-19 Vaccine

All except one36 of the articles included in this systematic review have clearly assessed the factors associated with acceptance of COVID-19 vaccine. According to this systematic review, almost half (10 out of 21) of the studies found a significant association between age category and vaccine acceptance.25,28,31,33,35,37–41 Among these, seven reported that age appeared to be positively associated with vaccine acceptance while the remaining three studies25,28,33 showed a negative association. Having good knowledge about the COVID-19 vaccine and/or its preventive measures was positively associated with vaccine acceptance.25,32,33,37,41–44 Higher educational level appeared to have a positive association with COVID-19 vaccine acceptance.30,33,37,41,42 Similarly, a positive attitude toward COVID-19 vaccine was significantly associated with increased vaccine acceptance rate.43,45,46

More than one-third of the studies in this systematic review reported a significant association between sex of participants and vaccine acceptance. Most of these studies found higher vaccine acceptance rate among males than females.28–30,32,39,40 Opposite to this finding, a couple of studies found higher vaccine acceptance in females than in males.25,33 Four studies revealed better vaccine acceptance among participants with history of chronic disease.32,34,37,46 High perceived risk of getting coronavirus infection,29,45,47 perceived severity of the disease,25 and perceived benefit of COVID-19 vaccine29,47 were positively associated with COVID-19 vaccine acceptance. Having good practice of COVID-19 preventive measures,34,38,42,44 access to the media,30 previous interaction with someone infected by COVID-19,26,30,46 urban residence,33,42 having children,26 being a physician or health professional,31,34,44 and being single28,33 also had a positive association with the acceptance of COVID-19 vaccine.

On the other hand, engagement with non-farm businesses,40 those who reported that it is dangerous to overdose vaccines and who said vaccinations increase allergic reactions, private sector worker,33 high perceived barrier,47 participants who do not trust the Ministry of Health to assure the safety of COVID-19 vaccine and do not trust science to produce safe and effective vaccines,35 were negatively associated with vaccine acceptance (Table 1).

Discussion

In this systematic review the vaccine acceptance rate was higher among older age groups,28,31,35,37–41 males,28–30,32,37,39 those who had attended secondary and above education,4,9,11,15,16 who are knowledgeable about COVID-19 vaccine,25,32,33,37,41,43,44 and perceive that COVID-19 causes a severe illness/death.25,26,29 The association between age and vaccine acceptance may be related with the fact that the impact of COVID-19 infection is more severe with increasing age, and older unvaccinated people are more likely to be hospitalized or die from COVID-19.48 As a result older people who perceive severity of the disease may be more likely to accept the vaccine. In line with the current finding, a survey conducted in 15 African countries found that males were more likely to accept the vaccine.49 The possible explanation for this association might be due to the fact that males have relatively better health-seeking behavior and decision-making power than females. The effect of knowledge on vaccine acceptance is obvious, i.e. people who get the correct information about the vaccine are more likely to have a positive attitude and willing to take the action.

Participants who had a family member or friend diagnosed with COVID-19,26,30 worked in a coronavirus treatment unit,28 tested for COVID-19,28,30 resided in urban areas,33,42 had a chronic disease,32,34,37 had access to the media, received any vaccine during childhood,30 had a positive attitude toward the COVID-19 vaccine,34,43 and perceiving their family as healthier than their counterparts, have children,26 previous interaction with someone infected by COVID-19,26 received immunization counseling during EPI,42 had good practice of COVID-19 preventive measures,34,41 do not have a health-related job, orthodox in religion,33 those with >10 years of work experience and those who had been working at the emergency department,35 who believe COVID-19 exists in the study area, who think that prevalence and death rate reports by the government are real,27 had perceived susceptibility and perceived benefit,29,47 who had health insurance, those who knew anyone diagnosed with COVID-19,43 being a private school teacher,29 being a health science student and being member of a family practicing COVID-19 prevention44 were more likely to accept the COVID-19 vaccine. On the other hand some studies found higher vaccine acceptance among younger age group (18–30 years), females,25,33 and those who experienced either previous or current COVID-19 infection.25

Acceptance of COVID-19 vaccine is lower among individuals who were not compliant with physical distancing, perceived unclear information by public health authorities, perceived low risk of getting COVID-19 infection, and not sure about the tolerability of the vaccine,38 only academic staff and academic staff working in university hospitals (compared with those who were health office staff),39 had no history of contact with confirmed COVID-19 patients compared with those who had direct contact with confirmed COVID-19 patients or clients,39 health-care workers other than medical doctors and/or nurses,31,34,35 participants who did not trust the Ministry of Health to assure the safety of COVID-19 vaccine, participants who do not trust science to produce safe and effective vaccine,35 who have close relatives or friends ever infected by COVID-1927 and those with perceived barrier.47 Supporting this evidence, a multi country survey conducted by African CDC team revealed that the majority of the vaccine-hesitant population had concerns on vaccine safety.49 This systematic review may have limitations, for example, as some of the studies collected the data through online systems, this may introduce sampling error and information biases. Meta-analyses were not done, instead the systematically searched studies have been qualitatively summarized.

Conclusion and Recommendation

Acceptance of COVID-19 vaccine in Ethiopia ranged from the lowest level of 31.4% to the highest level of 92.33%. A significant portion of the studies found that vaccine acceptance rate is below 50%. Variation of vaccine acceptance rate among different population groups is associated with socio-demographic factors (including age, sex, educational status, residence, occupational status, etc.), information-related factors (knowledge about COVID-19 vaccine, access to mass media, etc.) and other health-related behaviors. Dissemination of clear and adequate information concerning the vaccine’s benefit, effectiveness, safety, and side effects is the best prior activity to increase acceptance of the vaccine. Hesitancy, uncertainty, and rumors regarding the vaccine should be minimized by behavioral change communication. Hence, there should be coordinated efforts to halt the pandemic through increasing the acceptance of COVID-19 vaccine.

Abbreviations

COVID-19, coronavirus disease 19; ICTV, International Committee on Taxonomy of Viruses; JBI, Joanna Briggs Institute; JJU, Jigjiga University; SARS COV2, severe acute respiratory syndrome coronavVirus 2; WHO, World Health Organization.

Author Contributions

All authors made a significant contribution to the work in the conception, study design, execution, acquisition of data, analysis and interpretation of the result, took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Funding

The authors did not receive any fund to conduct this study.

Disclosure

Authors do not have any competing interests in this work.

References

1. World Health Organization (WHO). Coronavirus overview. [online]. Available from: https://www.who.int/health-topics/coronavirus#tab=tab_1. Accessed March 22, 2021.

2. International Pharmaceutical Federation. Coronavirus SARS-CoV-2/ OVID-19 Pandemic: information and interim guidelines for pharmacists and the pharmacy workforce. Advancing pharmacy worldwide; 2020.

3. Center for Disease Control and Prevention (CDC). SARS-CoV-2 and potential airborne transmission. [online]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/scientific-brief-sars-cov-2.html. Accessed March 22, 2021.

4. Center for Disease Control and Prevention (CDC). Symptoms of Coronavirus. [online]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/scientific-brief-sars-cov-2.html. Accessed March 22, 2021.

5. World Health Organization (WHO). Coronavirus disease (COVID-19) advice for the public. [Online]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public. Accessed March 25, 2021.

6. World Health Organization (WHO). WHO Coronavirus (COVID-19) Dashboard. [Online]. Available from: https://covid19.who.int/. Accessed April 10, 2021.

7. Sally H. Priority populations for COVID-19 vaccination: global timelines for deployment. United Kingdom: Pharma Inteligence Informa; 2020.

8. World Health Organization (WHO). WHO lists two additional COVID-19 vaccines for emergency use and COVAX roll-out. [Online]. Available from: https://www.who.int/news/item/15-02-2021-who-lists-two-additional-covid-19-vaccines-for-emergency-use-and-covax-roll-out. Accessed March 26, 2020.

9. World Health Organization (WHO). Coronavirus disease (COVID-19): vaccine access and allocation. [Online]. Available from: https://www.who.int/news-room/q-A-detail/coronavirus-disease-(covid-19)-vaccine-access-and-allocation. Accessed April 4, 2021.

10. Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021;9:160. doi:10.3390/vaccines9020160

11. Wake AD. The willingness to receive COVID-19 vaccine and its associated factors: “vaccination refusal could prolong the war of this pandemic” – a systematic review. Risk Manag Healthc Policy. 2021;14:2609–2623. doi:10.2147/RMHP.S311074

12. World Health Organization (WHO). Impact of COVID-19 on people’s livelihoods, their health and our food systems. Joint statement by ILO, FAO, IFAD and WHO; 2020. Availablve from: https://www.who.int/news/item/13-10-2020-impact-of-covid-19-on-people’s-livelihoods-their-health-and-our-food-systems. Accessed March 26, 2021.

13. Buheji M, da Costa Cunha K, Beka G, et al. The extent of covid-19 pandemic socio-economic impact on global poverty. a global integrative multidisciplinary review. Am J Econ. 2020;10(4):213–224. doi:10.5923/j.economics.20201004.02

14. Worldometer. COVID-19 Coronavirus pandemic. [Online]. Available from: https://www.worldometers.info/coronavirus/. Accessed April 11, 2021.

15. National Public Health Emergency Operation Center (PHEOC), Ethiopia. COVID-19 Pandemic preparedness and response in Ethiopia. Weekly Bulletin. FMoH and EPHI. Adiss Ababa; 2021.

16. Baye K. COVID-19 prevention measures in Ethiopia: current realities and prospects. Adiss Ababa: International Food Policy Research Institute (IFPRI); 2020.

17. Kassegn A, Endris E. Review on socio-economic impacts of :”Triple Threats” of COVID-19, desert locusts, and floods in East Africa: evidence from Ethiopia. Cogent Soc Sci. 2021;7(1):1885122. doi:10.1080/23311886.2021.1885122

18. National Disaster Risk Management Commission (NDRMC). Ethiopia: COVID-19 humanitarian impact situation update No. 15; 2020.

19. Aylie NS, Mekonen MA, Mekuria RM. The psychological impacts of COVID-19 pandemic among university students in Bench-Sheko Zone, South-west Ethiopia: a community-based cross-sectional study. Psychol Res Behav Manag. 2020;13:813–821. PMID: 33061696; PMCID: PMC7533263. doi:10.2147/PRBM.S275593

20. Mekonen EG, Workneh BS, Ali MS, Muluneh NY. The psychological impact of COVID-19 pandemic on graduating class students at the University of Gondar, Northwest Ethiopia. Psychol Res Behav Manag. 2021;14:109–122. PMID: 33603512; PMCID: PMC7881778. doi:10.2147/PRBM.S300262

21. Federal Ministry Of Health (FMoH). COVAX: COVID-19 vaccine. [Online]. Available from: http://www.moh.gov.et/am/COVAX. Accessed March 27, 2021.

22. Mohamed NA, Solehan HM, Mohd Rani MD, Ithnin M, Che Isahak CI. Knowledge, acceptance and perception on COVID-19 vaccine among Malaysians: A web-based survey. Plos one. 2021 Aug 13;16(8):e0256110.

23. Mekonnen BD, Mengistu BA. COVID-19 vaccine acceptance and its associated factors in Ethiopia: A systematic review and meta-analysis. Clinical Epidemiology and Global Health. 2022 Mar 7:101001.

24. Joanna Briggs Institute. Critical appraisal tools Australia: the University of Adelaide; 2018.[online]. Available from: http://joannabriggs.org/research/criticalappraisal-tools.html. Accessed December 2021.

25. Admasu FT. Knowledge and proportion of COVID-19 vaccination and associated factors among cancer patients attending public hospitals of Addis Ababa, Ethiopia, 2021: a Multicenter Study. Infect Drug Resist. 2021;14:4865–4876. doi:10.2147/IDR.S340324

26. Zewude B, Belachew A. Intention to receive the second round of COVID-19 vaccine among healthcare workers in Eastern Ethiopia. Infect Drug Resist. 2021;14:3071–3082. doi:10.2147/IDR.S326055

27. Zewude B, Habtegiorgis T. Willingness to take COVID-19 vaccine among people most at risk of exposure in Southern Ethiopia. Pragmatic Observ Res. 2021;12:37–47. doi:10.2147/POR.S313991

28. Kassaw C, Shumye S. Trust about Corona vaccine among health professionals working at Dilla University referral hospital. Elsevier; 2021.

29. Shitu K, Wolde M, Handebo S, Kassie A. Acceptance and willingness to pay for COVID-19 vaccine among school teachers in Gondar City, Northwest Ethiopia. Trop Med Health. 2021;49:63. doi:10.1186/s41182-021-00337-9

30. Molalegn M. COVID-19 vaccination acceptance and its associated factors in Sodo Town, Wolaita Zone, Southern Ethiopia: cross-Sectional Study. Infect Drug Resist. 2021;14:2361–2367. doi:10.2147/IDR.S320771

31. Alle YF, Oumer KE. Attitude and associated factors of COVID-19 vaccine acceptance among health professionals in Debre Tabor Comprehensive Specialized Hospital, North Central Ethiopia; 2021: crosssectional study. Indian Virol Soc. 2021;33(2):272–278.

32. Mesfin Y, Argaw M, Geze S, Zewdu BT. Factors associated with intention to receive COVID-19 vaccine among HIV positive patients attending ART clinic in Southwest Ethiopia. Patient Prefer Adherence. 2021;15:2731–2738. doi:10.2147/PPA.S342801

33. Belsti Y, Gela YY, Akalu Y, et al. Willingness of Ethiopian population to receive COVID-19 vaccine. J Multidiscip Healthc. 2021;14:1233–1243. doi:10.2147/JMDH.S312637

34. Angelo AT, Alemayehu DS, Dachew AM. Health care workers intention to accept COVID-19 vaccine and associated factors in southwestern Ethiopia. PLoS One. 2021;16(9):e0257109. doi:10.1371/journal.pone.0257109

35. Mohammed R, Nguse TM, Habte BM, Fentie AM, Gebretekle GB. COVID-19 vaccine hesitancy among Ethiopian healthcare workers. PLoS One. 2021;16(12):e0261125. doi:10.1371/journal.pone.0261125

36. Guangul BA, Georgescu G, Osman M, et al. Healthcare workers attitude towards SARS-COVID-2 Vaccine, Ethiopia. Glob J Infect Dis Clin Res. 2021;7(1):043–048. doi:10.17352/2455-5363.000045

37. Abebe H, Shitu S, Mose A. Understanding of COVID-19 vaccine knowledge, attitude, acceptance, and determinates of COVID-19 vaccine acceptance among adult population in Ethiopia. Infect Drug Resist. 2021;14:2015–2025. doi:10.2147/IDR.S312116

38. Aemro A, Amare NS, Shetie B, Chekol B, Wassie M. Determinants of COVID-19 vaccine hesitancy among health care workers in Amhara region referral hospitals, Northwest Ethiopia: a cross-sectional study. Epidemiol Infect. 2021;149(e225):1–8. doi:10.1017/S0950268821002259

39. Terefa DR, Shama AT, Feyisa BR, et al. COVID-19 vaccine uptake and associated factors among health professionals in Ethiopia. Infect Drug Resist. 2021;14:5531–5541. doi:10.2147/IDR.S344647

40. Oyekale AS. Willingness to take COVID-19 vaccines in Ethiopia: an instrumental variable probit approach. Int J Environ Res Public Health. 2021;18:8892. doi:10.3390/ijerph18178892

41. Mose A, Yeshaneh A. COVID-19 vaccine acceptance and its associated factors among pregnant women attending antenatal care clinic in Southwest Ethiopia: institutional-based cross-sectional study. Int J Gen Med. 2021;14:2385–2395. doi:10.2147/IJGM.S314346

42. Mose A. Willingness to receive COVID-19 vaccine and its determinant factors among lactating mothers in Ethiopia: a cross-sectional study. Infect Drug Resist. 2021;14:4249–4259. doi:10.2147/IDR.S336486

43. Berihun G, Walle Z, Berhanu L, Teshome D. Acceptance of COVID-19 vaccine and determinant factors among patients with chronic disease visiting Dessie comprehensive specialized hospital, Northeastern Ethiopia. Patient Prefer Adherence. 2021;15:1795–1805. doi:10.2147/PPA.S324564

44. Taye BT, Amogne FK, Demisse TL, et al. Coronavirus disease 2019 vaccine acceptance and perceived barriers among university students in northeast Ethiopia: a cross-sectional study Clinical Epidemiology and Global Health. Elsevier; 2021.

45. Angelo AT, Alemayehu DS, Dacho AM. Knowledge, attitudes, and practices toward Covid-19 and associated factors among university students in Mizan Tepi University, 2020. Infect Drug Resist. 2021;14:349. doi:10.2147/IDR.S299576

46. Zewude B, Habtegiorgis T, Hizkea A, Dela T, Siraw G. Perceptions and experiences of COVID-19 vaccine side-effects among healthcare workers in Southern Ethiopia: a cross-sectional study. Pragmatic Observ Res. 2021;12:131–145. doi:10.2147/POR.S344848

47. Handebo S, Wolde M, Shitu K, Kassie A. Determinant of intention to receive COVID- 19 vaccine among school teachers in Gondar City, Northwest Ethiopia. PLoS One. 2021;16(6):e0253499. doi:10.1371/journal.pone.0253499

48. Hajure M, Tariku M, Bekele F, et al. Attitude towards COVID-19 vaccination among healthcare workers: a systematic review. Infect Drug Resist. 2021;14:3883–3897. doi:10.2147/IDR.S332792

49. Africa CDC. COVID-19 vaccine perceptions: a 15-country study. CDC Africa COVID-19 vaccine perceptions 2020; 2021. Available from: https://africacdc.org/download/covid-19-vaccine-perceptions-A-15-country-study/. Accessed April 17, 2022.

50. Moher D, Liberati A, Altman D, Tetzlaff J,et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Journal of clinical epidemiology. 2009;62(10).

Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.